Discover
PCSA
Processa Pharmaceuticals, Inc.
1.68
2 x 1.13
11 x 1.50
bid
ask
+
0.06
4.02%
7 @ 04:00 PM
1.66 -0.02 (1.19%)
| Ytd | -41.67% | |
| 1y | -83.61% |
1.53
day range
1.72
1.04
52 week range
10.85
| Open | 1.58 | Prev Close | 1.61 | Low | 1.53 | High | 1.72 | Mkt Cap | 4.70M |
| Vol | 31.15K | Avg Vol | 275.01K | EPS | -4.33 | P/E | N/A | Forward P/E | -0.39 |
| Beta | 0.60 | Short Ratio | 2.45 | Inst. Own | 1.49% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 1.99 | 200-d Avg | 2.45 | 1yr Est | 6.00 |
| Income Statement | |||
| Operating Expenses | 2.34M | ||
| Research and Development Expense | 649.88K | ||
| Selling, General and Administrative Expense | 1.69M | ||
| Operating Income | -2.34M | ||
| Interest Expense | 2.00K | ||
| Net Income | -3.27M | ||
| Net Income Common Stock | -3.27M | ||
| Net Income Common Stock (USD) | -3.27M | ||
| Consolidated Income | -3.27M | ||
| Earnings per Basic Share | -1.19 | ||
| Earnings per Basic Share (USD) | -1.19 | ||
| Earnings per Diluted Share | -1.19 | ||
| Earning Before Interest & Taxes (EBIT) | -3.26M | ||
| Earning Before Interest & Taxes (USD) | -3.26M | ||
| Weighted Average Shares | 2.75M | ||
| Weighted Average Shares Diluted | 2.75M | ||
| Balance Sheet | |||
| Cash and Equivalents | 196.33K | ||
| Cash and Equivalents (USD) | 196.33K | ||
| Investments | 472.00K | ||
| Investments Current | 472.00K | ||
| Current Assets | 2.07M | ||
| Property, Plant & Equipment Net | 3.21K | ||
| Total Assets | 2.07M | ||
| Current Liabilities | 2.39M | ||
| Total Liabilities | 2.39M | ||
| Accumulated Retained Earnings (Deficit) | -107.43M | ||
| Shareholders Equity | -317.34K | ||
| Shareholders Equity (USD) | -317.34K | ||
| Assets Non-Current | 3.21K | ||
| Trade and Non-Trade Payables | 1.66M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 301.00 | ||
| Net Cash Flow from Financing | 315.17K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.49M | ||
| Issuance (Purchase) of Equity Shares | 315.17K | ||
| Net Cash Flow from Investing | 186.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 186.00K | ||
| Net Cash Flow from Operations | -2.00M | ||
| Share Based Compensation | 92.11K | ||